A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage-Reference-Cited by-同舟云学术

A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage

Published:2023-11 Issue: Volume: Page:
ISSN:2589-238X
Container-title:Brain Hemorrhages
language:en
Short-container-title:Brain Hemorrhages

Author:

Nishii Rikuo^ORCID,Ohta Tsuyoshi,Fukui Nobuyuki^ORCID,Koyanagi Masaomi^ORCID,Goto Masanori^ORCID,Takeda Junichi,Fukumitsu Ryu^ORCID,Sunohara Tadashi^ORCID,Takano Yuki,Teranishi Kunimasa,Nakajima Kota,Naramoto Yuji^ORCID,Yamamoto Yasuhiro^ORCID,Kawade Satohiro,Sakisuka Ryo^ORCID,Takamatsu Takateru^ORCID,Tokuda Masanori,Tomita Hikari,Yoshimoto Mai,Sakai Nobuyuki^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Neuroscience (miscellaneous),Surgery

Reference22 articles.

1. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: A systematic review and meta-analysis;Etminan;JAMA Neurol,2019

2. Incidence and outcome of aneurysmal subarachnoid hemorrhage: The swiss study on subarachnoid hemorrhage (Swiss SOS);Schatlo;Stroke,2021

3. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients;Endo;J Neurosurg,2022

4. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study;Vajkoczy;J Neurosurg,2005

5. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial;Macdonald;Stroke,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Progressive Frontier of Aneurysmal subarachnoid Hemorrhage: Diagnosis and treatment Advances;Brain Hemorrhages;2024-09

2. Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan;Neurosurgical Review;2024-03-13

3. Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?;Brain Hemorrhages;2023-12